Patents by Inventor Jewel Payne

Jewel Payne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7511129
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: March 31, 2009
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Publication number: 20070118924
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Application
    Filed: November 17, 2006
    Publication date: May 24, 2007
    Applicant: Mycogen Corporation
    Inventors: Jewel Payne, August Sick
  • Patent number: 7138568
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: November 21, 2006
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 6737273
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: May 18, 2004
    Assignee: Myocogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Publication number: 20040058860
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Application
    Filed: April 19, 2001
    Publication date: March 25, 2004
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 6689743
    Abstract: Disclosed claimed are toxins produced by novel Bacillus thuringiensis isolates designated B.t. PS92J, B.t. PS196S1, B.t. PS201L1, and B.t. PS201T6, which have dipteran and/or corn rootworm activity. Thus, the isolates, or mutants therof, can be used to control such pests. Further, claimed are novel genes encoding these &dgr;-endotoxins, which can be expressed in other hosts. Expression of the &dgr;-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: November 3, 2000
    Date of Patent: February 10, 2004
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Kendrick Akira Uyeda, Christine Julie Stalder, Tracy Ellis Michaels
  • Publication number: 20040018982
    Abstract: This invention concerns nematicidal proteins obtainable from Bacillus thuringiensis isolates. The subject invention also provides various methods of using these proteins for controlling nematodes.
    Type: Application
    Filed: July 31, 2003
    Publication date: January 29, 2004
    Inventors: H. Ernest Schnepf, George E. Schwab, Jewel Payne, Kenneth E. Narva, Luis Foncerrada
  • Patent number: 6632792
    Abstract: This invention concerns nematicidal proteins obtainable from Bacillus thuringiensis isolates. The subject invention also provides various methods of using these proteins for controlling nematodes.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: October 14, 2003
    Assignee: Mycogen Corporation
    Inventors: H. Ernest Schnepf, George E. Schwab, Jewel Payne, Kenneth E. Narva, Luis Foncerrada
  • Patent number: 6573240
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: June 3, 2003
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Publication number: 20010010932
    Abstract: This invention concerns nematicidal proteins obtainable from Bacillus thuringiensis isolates. The subject invention also provides various methods of using these proteins for controlling nematodes.
    Type: Application
    Filed: December 15, 2000
    Publication date: August 2, 2001
    Applicant: Mycogen Corporation
    Inventors: H. Ernest Schnepf, George E. Schwab, Jewel Payne, Kenneth E. Narva, Luis Foncerrada
  • Patent number: 6166195
    Abstract: This invention concerns genes or gene fragments which have been cloned from novel Bacillus thuringiensis isolates which have nematicidal activity. These genes or gene fragments can be used to transform suitable hosts for controlling nematodes.
    Type: Grant
    Filed: May 12, 1998
    Date of Patent: December 26, 2000
    Assignee: Mycogen Corporation
    Inventors: H. Ernest Schnepf, George E. Schwab, Jewel Payne, Kenneth E. Narva, Luis Foncerrada
  • Patent number: 6150165
    Abstract: Disclosed and claimed are approximately 130 kDa toxins produced by Bacillus thuringiensis PS201T6, which can be used to control pests. Further, claimed are novel genes encoding these .delta.-endotoxins, which can be expressed in other hosts. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: November 21, 2000
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Kendrick Akira Uyeda, Christine Julie Stalder, Tracy Ellis Michaels
  • Patent number: 6150589
    Abstract: Novel B.t. genes encoding toxins active against lepidopteran insects have been cloned from a novel lepidopteran-active B. thuringiensis isolate P515862. The DNA encoding the B.t. toxin can be used to transform various hosts to express the B.t. toxin.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: November 21, 2000
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, David A. Cummings, Raymond J. C. Cannon, Kenneth E. Narva, Steve Stelman
  • Patent number: 6096708
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: August 1, 2000
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 6056953
    Abstract: Methods and compositions for the control of pests of the family Calliphoridae are described. Specifically, Bacillus thuringiensis (B.t.) isolates having anti-calliphorid activity are disclosed. Also described are recombinant hosts which express B.t. genes coding for pesticidal toxins. The B.t. isolates and recombinant proteins are shown to be useful in a method for controlling calliphorids including screw-worms and the sheep blowfly.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: May 2, 2000
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Jewel Payne
  • Patent number: 5985267
    Abstract: Disclosed and claimed are novel Bacillus thuringiensis isolates which have lepidopteran activity. Thus, these isolates, or mutants thereof, can be used to control such insect pests. Further, genes encoding novel .delta.-endotoxins can be removed from the isolates and transferred to other host microbes, or plants. Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: November 16, 1999
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Kenneth E. Narva, H. Ernest Schnepf, George E. Schwab
  • Patent number: 5959080
    Abstract: Noven B.t. genes encoding toxins active against nematode pests have been cloned. The DNA encoding the B.t. toxin can be used to transform various hosts to express the B.t. toxin.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: September 28, 1999
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Jenny Fu
  • Patent number: 5888976
    Abstract: Disclosed and claimed are toxins produced by novel Bacillus thuringiensis insolates designated B.t. PS92J, B.t. PS196S1, B.t. PS201L1; and B.t. PS201T6, which have dipteran and/or corn rootworm activity. Thus, the insolates, or mutants thereof, can be used to control such pests. Further, claimed are novel genes encoding these .delta.-emdotoxins, which can be expressed in other hosts, Expression of the .delta.-endotoxins in such hosts results in the control of susceptible insect pests in the environment of such hosts.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: March 30, 1999
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Kendrick Akira Uyeda, Christine Julie Stalder, Tracy Ellis Michaels
  • Patent number: 5888503
    Abstract: Methods and compositions for the control of pests of the family Calliphoridae are described. Specifically, Bacillus thuringiensis (B.t.) isolates having anti-calliphorid activity are disclosed. Also described are recombinant hosts which express B.t. genes coding for pesticidal toxins. The B.t. isolates and recombinant proteins are shown to be useful in a method for controlling calliphorids including screw-worms and the sheep blowfly.
    Type: Grant
    Filed: May 14, 1997
    Date of Patent: March 30, 1999
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Jewel Payne
  • Patent number: 5831011
    Abstract: Novel B.t. genes encoding toxins active against nematode pests have been cloned. The DNA encoding the B.t. toxin can be used to transform various hosts to express the B.t. toxin.
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: November 3, 1998
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, Kenneth E. Narva, Jenny Fu